Suma Krishnan (President, R&D) sold ~$105K of Krystal Biotech
Scheduled in advanceLoading…
Traded Feb 19, 2026 · Filed Feb 24, 2026
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
option exercise
Code M — exercise or conversion of a derivative security
None found in footnotes
Only flagged when a footnote says so; never inferred
Suma Krishnan (President, R&D) sold ~$105K of Krystal Biotech
Scheduled in advanceSuma Krishnan (President, R&D) sold ~$152K of Krystal Biotech
Automatic saleSuma Krishnan (President, R&D) sold ~$173K of Krystal Biotech
Automatic sale